A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins

Virology

Volumn 345, Issue 2, 2006, Pages 299-304

  Bredenbeek, Peter J ^a   Molenkamp, Richard ^a   Spaan, Willy J M ^a   Deubel, Vincent ^b   Marianneau, Phillippe ^b   Salvato, Maria S ^c   Moshkoff, Dmitry ^c   Zapata, Juan ^c   Tikhonov, Ilia ^c   Patterson, Jean ^d   Carrion, Ricardo ^d   Ticer, Anysha ^d   Brasky, Kathleen ^d   Lukashevich, Igor S ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Institut Pasteur   (France)

^c INSTITUTE OF HUMAN VIROLOGY   (United States)

^d SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Recombinant vaccine; Yellow and Lassa Fevers; YFV17D vaccine

Indexed keywords

GLYCOPROTEIN; RECOMBINANT VACCINE; YELLOW FEVER VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; GUINEA PIG; HISTOPATHOLOGY; LASSA FEVER; LASSA VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS RECOMBINANT; VIRUS REPLICATION; YELLOW FEVER; YELLOW FEVER FLAVIVIRUS;

ANIMALS; GLYCOPROTEINS; GUINEA PIGS; HUMANS; LASSA FEVER; LASSA VIRUS; VACCINES, SYNTHETIC; VIRAL VACCINES; YELLOW FEVER; YELLOW FEVER VACCINE; YELLOW FEVER VIRUS;

ANIMALIA; CAVIA; CAVIA PORCELLUS; LASSA VIRUS; YELLOW FEVER VIRUS;

EID: 31944447643     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2005.12.001     Document Type: Article

References (20)

1. G. Barba-Spaeth, R.S. Longman, M.L. Albert, and C.M. Rice Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes J. Exp. Med. 202 9 2005 1179 1184
2. M.C. Bonaldo, R.C. Garratt, R.S. Marchevsky, E.S.F. Coutinho, A.V. Jabor, L.F.C. Almeida, A.M.Y. Yamamura, A.S. Duarte, P.J. Oliveira, J.O.P. Lizeu, L.A.B. Camacho, M.S. Freire, and R. Galler Attenuation of recombinant yellow fever 17D viruses expressing foreign protein epitopes at the surface J. Virol. 79 13 2005 8602 8613
3. L. Borio, T. Inglesby, C.J. Peters, A.L. Schmaljohn, J.M. Hughes, P.B. Jahrling, T. Ksiazek, K.M. Johnson, A. Meyerhoff, T. O'Toole, M.S. Ascher, J. Bartlett, J.G. Breman, E.M.J. Eitzen, M. Hamburg, J. Hauer, D.A. Henderson, R.T. Johnson, G. Kwik, M. Layton, S. Lillibridge, G.J. Nabel, M.T. Osterholm, T.M. Perl, P. Russell, and K. Tonat Hemorrhagic fever viruses as biological weapons: medical and public health management JAMA 287 18 2002 2391 2405
4. P.J. Bredenbeek, E.A. Kooi, B. Lindenbach, N. Huijkman, C.M. Rice, and W.J.M. Spaan A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication J. Gen. Virol. 84 5 2003 1261 1268
5. R. Eichler, O. Lenz, T. Strecker, M. Eickmann, H.D. Klenk, and W. Garten Identification of Lassa virus glycoprotein signal peptide as a trans-acting maturation factor EMBO Rep. 4 11 2003 1084 1088
6. S.P. Fisher-Hoch, and J.B. McCormick Lassa fever vaccine Expert Rev. Vaccines 3 2 2004 103 111
7. T.W. Geisbert, S. Jones, E.A. Fritz, A.C. Shurtleff, J.B. Geisbert, R. Liebscher, A. Grolla, U. Stroher, L. Fernando, K.M. Daddario, M.C. Guttieri, B.R. Mothe, T. Larsen, L.E. Hensley, P.B. Jahrling, and H. Feldmann Development of a new vaccine for the prevention of Lassa fever PLoS Med. 2 6 2005 537 545
8. S. Gunther, P. Emmerich, T. Laue, O. Kuhle, M. Asper, A. Jung, T. Grewing, J. ter Meulen, and H. Schmitz Imported lassa fever in Germany: molecular characterization of a new lassa fever strain Emerging Infect. Dis. 6 5 2000 466 476
9. O. Lenz, J. ter Meulen, H. Feldmann, H.-D. Klenk, and W. Garten Identification of a novel consensus sequence at the cleavage site of the lassa virus glycoprotein J. Virol. 74 23 2000 11418 11421
10. I.S. Lukashevich, J. Patterson, R. Carrion, D. Moshkoff, A. Ticer, J. Zapata, K. Brasky, R. Geiger, G.H. Hubbard, J. Bryant, and M.S. Salvato A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses J. Virol. 79 22 2005 13934 13942
11. A. McAllister, A.E. Arbetman, S. Mandl, C. Pena-Rossi, and R. Andino Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases J. Virol. 74 19 2000 9197 9205
12. J.B. McCormick, and S.P. Fisher-Hoch Lassa fever Curr. Top. Microbiol. Immunol. 262 2002 75 109
13. T.P. Monath Yellow Fever Vaccine Vaccines 4th ed. 2004 Saunder Plotkin SA, Orenstein WA 1095 1176
14. M.B. Oldstone, H. Lewicki, D. Homann, C. Nguyen, S. Julien, and J.E. Gairin Common antiviral cytotoxic T-lymphocyte epitope for diverse arenaviruses J. Virol. 75 14 2001 6273 6278
15. C.J. Peters, P.B. Jahrling, C.T. Liu, R.H. Kenyon, K.T. McKee Jr., and J.G.B. Oro Experimental studies of arenaviral hemorrhagic fevers Curr. Top. Microbiol. Immunol. 134 1987 5 68
16. P. Pushko, J. Geisbert, M. Parker, P. Jahrling, and J. Smith Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses J. Virol. 75 23 2001 11677 11685
17. M.P. Rodriguez-Carreno, M.S. Nelson, J. Botten, K. Smith-Nixon, M.J. Buchmeier, and J.L. Whitton Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein Virology 335 1 2005 87 98
18. M.S. Salvato, J.C.S. Clegg, M.J. Buchmeier, R.N. Charrel, J.-P. Gonzalez, I.S. Lukashevich, C.J. Peters, R. Rico-Hesse, and V. Romanowski Arenaviridae C.M. Fauquet M.A. Mayo J. Maniloff U. Desselberger L.A. Ball Virus Taxonomy, VIIIth Report of the ICTV 2005 Elsevier/Academic Press London 725 733
19. D. Tao, G. Barba-Spaeth, U. Rai, V. Nussenzweig, C.M. Rice, and R.S. Nussenzweig Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model J. Exp. Med. 201 2 2005 201 209
20. J. ter Meulen, M. Badusche, K. Kuhnt, A. Doetze, J. Satoguina, T. Marti, C. Loeliger, K. Koulemou, L. Koivogui, H. Schmitz, B. Fleischer, and A. Hoerauf Characterization of human CD4+T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein J. Virol. 74 5 2000 2186 2192